company background image
4015 logo

Jamjoom Pharmaceuticals Factory SASE:4015 Stock Report

Last Price

ر.س141.00

Market Cap

ر.س9.9b

7D

2.2%

1Y

n/a

Updated

16 Jun, 2024

Data

Company Financials +

Jamjoom Pharmaceuticals Factory Company

SASE:4015 Stock Report

Market Cap: ر.س9.9b

4015 Stock Overview

Manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally.

4015 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth3/6
Past Performance6/6
Financial Health6/6
Dividends2/6

Jamjoom Pharmaceuticals Factory Company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Jamjoom Pharmaceuticals Factory
Historical stock prices
Current Share Priceر.س141.00
52 Week Highر.س158.20
52 Week Lowر.س66.00
Beta0
1 Month Change3.07%
3 Month Change3.22%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO80.77%

Recent News & Updates

Getting In Cheap On Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015) Is Unlikely

Apr 30
Getting In Cheap On Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015) Is Unlikely

Recent updates

Getting In Cheap On Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015) Is Unlikely

Apr 30
Getting In Cheap On Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015) Is Unlikely

Shareholder Returns

4015SA PharmaceuticalsSA Market
7D2.2%-1.0%-1.6%
1Yn/a1.5%-10.5%

Return vs Industry: Insufficient data to determine how 4015 performed against the SA Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how 4015 performed against the SA Market.

Price Volatility

Is 4015's price volatile compared to industry and market?
4015 volatility
4015 Average Weekly Movement4.0%
Pharmaceuticals Industry Average Movement5.2%
Market Average Movement4.8%
10% most volatile stocks in SA Market7.8%
10% least volatile stocks in SA Market2.6%

Stable Share Price: 4015 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4015's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19941,255Tarek Youssef Hosniwww.jamjoompharma.com

Jamjoom Pharmaceuticals Factory Company manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally. The company offers products human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer, and acidity, as well as various skin infections, cancer diseases, eye drops and ointments, and cosmeceuticals. Jamjoom Pharmaceuticals Factory Company was founded in 1994 and is based in Jeddah, the Kingdom of Saudi Arabia.

Jamjoom Pharmaceuticals Factory Company Fundamentals Summary

How do Jamjoom Pharmaceuticals Factory's earnings and revenue compare to its market cap?
4015 fundamental statistics
Market capر.س9.87b
Earnings (TTM)ر.س310.97m
Revenue (TTM)ر.س1.19b

31.7x

P/E Ratio

8.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4015 income statement (TTM)
Revenueر.س1.19b
Cost of Revenueر.س433.89m
Gross Profitر.س751.54m
Other Expensesر.س440.57m
Earningsر.س310.97m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)4.44
Gross Margin63.40%
Net Profit Margin26.23%
Debt/Equity Ratio0%

How did 4015 perform over the long term?

See historical performance and comparison

Dividends

2.1%

Current Dividend Yield

56%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.